CTLP · As filed with the SEC

Cantaloupe balance sheet, by quarter

The statement as Cantaloupe presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.

Condensed Consolidated Balance Sheets · USD thousands

USD thousandsQ3 FY26
Mar 31, 2026
Q2 FY26
Dec 31, 2025
Q1 FY26
Sep 30, 2025
Q4 FY25
Jun 30, 2025
Assets
Current assets:
Cash and cash equivalents60,41352,98054,98551,146
Accounts receivable, net39,79936,81341,86237,927
Finance receivables, net5,5635,7705,2535,422
Inventory, net50,82850,71747,65545,703
Prepaid expenses and other current assets14,77113,64213,71112,727
Total current assets171,374159,922163,466152,925
Non-current assets:
Finance receivables, net2,7353,5595,0765,750
Property and equipment, net40,44240,23339,76139,125
Operating lease right-of-use assets6,7737,1117,5157,735
Intangibles, net18,97120,40521,83523,331
Goodwill102,939103,071103,075103,222
Deferred income taxes, net39,11740,52941,56843,253
Other assets6,6527,1137,2186,517
Total non-current assets217,629222,021226,048228,933
Total assets389,003381,943389,514381,858
Liabilities, convertible preferred stock, and shareholders’ equity
Current liabilities:
Accounts payable57,26852,33161,74158,741
Accrued expenses30,60725,34622,48019,748
Current obligations under long-term debt——1,9361,917
Current obligations under long-term debt2,1701,919——
Deferred revenue3,3503,6453,9751,990
Total current liabilities93,39583,24190,13282,396
Long-term liabilities:
Deferred income taxes, net———0
Long-term debt, less current portion35,05635,78636,35336,746
Other noncurrent liabilities7,4107,7408,4718,965
Total long-term liabilities42,46643,52644,82445,711
Total liabilities135,861126,767134,956128,107
Convertible preferred stock:
Series A convertible preferred stock, 900,000 shares authorized, 383,782 and 385,782 issued and outstanding, with liquidation preferences of $23,860 and $23,301 at March 31, 2026 and June 30, 2025, respectively2,7062,7202,7202,720
Shareholders’ equity:
Common stock, no par value, 640,000,000 shares authorized, 73,733,567 and 73,289,054 shares issued and outstanding at March 31, 2026 and June 30, 2025, respectively0000
Additional paid-in capital489,629488,924488,557486,759
Accumulated deficit(239,073)(236,915)(236,845)(235,926)
Accumulated other comprehensive income (loss)(120)447126198
Total shareholders’ equity250,436252,456251,838251,031
Total liabilities, convertible preferred stock, and shareholders’ equity389,003381,943389,514381,858

As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.